Home Newsfeeds Morgan Stanley Upgrades CAE to Overweight

Morgan Stanley Upgrades CAE to Overweight

Morgan Stanley analyst Kristine Liwag upgrades CAE (NYSE:CAE) from Equal-Weight to Overweight.

byBenzinga Newsdesk

December 12, 2022

1 minute read

Morgan Stanley analyst Kristine Liwag upgrades CAE (NYSE:CAE) from Equal-Weight to Overweight.

Top Crypto Analyst Says Bitcoin Could Retest All-Time High, ‘If It Holds Above $69K’

By Benzinga Neuro

April 9, 7:55 AM

Renowned crypto analyst Michaël van de Poppe has indicated that Bitcoin (CRYPTO: BTC) could be on the verge of testing its all-time high, contingent on its ability to maintain a key price level.

BTC

Analyst Ratings

What 11 Analyst Ratings Have To Say About C.H. Robinson Worldwide

By Benzinga Insights

April 27, 9:01 AM

Analysts have provided the following ratings for C.H. Robinson Worldwide (NASDAQ:CHRW) within the last quarter: Bullish Somewhat Bullish…

CHRW

Verizon, Netflix And 3 Stocks To Watch Heading Into Tuesday

By Avi Kapoor

January 23, 2:53 AM

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

JNJ

GlucoTrack Announces Early Accuracy Data For Its Implantable Continuous Glucose Monitor; Announces The Successful Completion Of Their First Preclinical Study Of The Implantable CBGM

By Benzinga Newsdesk

January 2, 1:34 PM

GlucoTrack, Inc. (NASDAQ:GCTK) ("GlucoTrack" or the "Company"), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, provides, updates on

GCTK

Morgan Stanley Upgrades CAE to Overweight

Related Posts

Top Crypto Analyst Says Bitcoin Could Retest All-Time High, ‘If It Holds Above $69K’

What 11 Analyst Ratings Have To Say About C.H. Robinson Worldwide

Verizon, Netflix And 3 Stocks To Watch Heading Into Tuesday

GlucoTrack Announces Early Accuracy Data For Its Implantable Continuous Glucose Monitor; Announces The Successful Completion Of Their First Preclinical Study Of The Implantable CBGM